bioAffinity Technologies Balance Sheet Health
Financial Health criteria checks 3/6
bioAffinity Technologies has a total shareholder equity of $5.3M and total debt of $27.7K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are $8.0M and $2.8M respectively.
Key information
0.5%
Debt to equity ratio
US$27.72k
Debt
Interest coverage ratio | n/a |
Cash | US$2.45m |
Equity | US$5.26m |
Total liabilities | US$2.79m |
Total assets | US$8.05m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: BIAF's short term assets ($3.9M) exceed its short term liabilities ($1.8M).
Long Term Liabilities: BIAF's short term assets ($3.9M) exceed its long term liabilities ($1.0M).
Debt to Equity History and Analysis
Debt Level: BIAF has more cash than its total debt.
Reducing Debt: Insufficient data to determine if BIAF's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIAF has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BIAF has less than a year of cash runway if free cash flow continues to reduce at historical rates of 44.5% each year